Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019163 (hepatitis B)
 38,309 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A study was undertaken to assess the state of hepatitis B virus infection in a group of asymptomatic hepatitis B surface antigen (HBsAg) carriers. This study confirmed that the presence of hepatitis B e antigen (HBeAg) in serum was closely associated with serum HBsAg-specific deoxyribonucleic acid polymerase activity, hepatitis B core antigen (HBcAg) in serum and liver cell nuclei, and a histological picture of chronic hepatitis. No HBsAg-specific deoxyribonucleic acid polymerase activity or HBcAg was detected in highly concentrated anti-HBe-positive sera. In addition, liver biopsy specimens from carriers with anti-HBe were negative for HbcAg by immunofluorescence, and the liver histology was either normal or revealed only fatty changes. These data indicate that the anti-HBe-positive sera contained either no Dane particles or, if present, at least a 500-fold-lower concentration of Dane particles than that found in HBeAg-positive sera.
 ...
PMID:Expression of hepatitis B virus-specific markers in asymptomatic hepatitis B surface antigen carriers. 7 Dec 67

A method of preparation of subtypical antisera to two determinants of hepatitis B surface antigen (anti-HBs Ag/ay and anti-HBs Ag/ad) is described. The test system obtained was approbated on 1400 antigen-positive sera collected from blood donors and patients suffering from acute and chronic virus hepatitis in various geographical zones of the USSR. HBs Ag/ay proved to prevail (84--100%), HBs Ag/ad was distributed irregularly--from 16% in the European part of the USSR to 0--4% in the republics of the Middle Asia and Siberian regions. HBs Ag/ad was mostly determined in the population of Western regions of the European part of the USSR (the Baltic republics, 43.4%, Moldavia 24.3%).
 ...
PMID:[Subtype characteristics of the surface antigen of hepatitis B in different regions of the USSR]. 7 69

Serums containing the "e" antigen of hepatitis B virus were subjected to electrophoresis in polyacrylamide gel. An extra band appeared in the lactate dehydrogenase isozyme pattern, but this band was undetectable in serums containing antibodies to the e antigenic determinant. Prior separation of the lactate dehydrogenase isozyme-5 fraction by chromatography of serum on minicolumns of diethylaminoethyl-Sephadex-A50 improved electrophoretic identification of the extra band. Neutralization with antibodies to the e antigen as well as by antibodies to the homologous d or y component of the hepatitis B surface antigen removed the extra band; antibodies to the lactate dehydrogenase isozyme-5 removed both the normal and the extra enzymatic band of isozyme-5. This feature of the e antigen provides an assay system for laboratory diagnosis of potential clinical usefulness and suggests its possible role in pathogenesis of hepatocellular injury.
 ...
PMID:Hepatitis B "e" antigen: an apparent association with lactate dehydrogenase isozyme-5. 7 21

Hepatitis B surface antigen (HBsAg) in epoxy-embedded liver tissues can be stained by aldehyde-fuchsin stain. Sections are oxidized in KMnO4 acidified with H2SO4, then bleached in NaHSO3, both at 70 C. Heating for oxidation and bleaching are absolutely necessary. Diluted aldehyde-fuchsin stain adjusted to pH 1.5 to 1.8 with NaOH is used for staining. HBsAg is specifically stained purple. Other components such as mitochondria and bile pigments are also strained, but are easily distinguished from HBsAg. This staining method is advantageous for the identification of HBsAg-positive cells for electron microscopic observation.
 ...
PMID:Selective staining of hepatitis B surface antigen in thick epoxy sections of liver. 7 37

Paraffin sections of liver on 227 autopsy cases were stained by a modified orcein method of Shikata et al (14) in order to detect hepatitis B surface antigen (HBsAg). Blood of all the 227 cases obtained at autopsy were tested for HBsAg by immune adherence hamagglutination method (7) and for antibody to HBsAg (anti-HBs) by passive hemagglutination method (6). Cases of seropositive in HBsAg but negative in anti-HBs group showed orcein-positive hapatocyte in 13 (68%) of 19 cases of cirrhosis with hepatoma, in 2 (67%) of 3 cases of cirrhosis without hepatoma, and in 2 (67%) of 3 cases of non-cirrhotic neoplastic diseases other than hepatoma. Cases of seronegative in both HBsAg and anti-HBs group showed orceinpositive hepatocyte in 4 (17%) of 24 cases of cirrhosis with hepatoma, in 2 (11%) of 19 cases of cirrhosis without hepatoma, and in 3 (5%) of 60 cases of non-cirrhotic neoplastic diseases other than hepatoma. Cases of seronegative in HBsAg but positive in anti-HBsAg but positive in anti-HBs group showed orcein-positive hepatocyte in 1 (17%) of 6 cases of cirrhosis with hepatoma and in 1 (5%) of 21 cases of non-cirrhotic neoplastic diseases other than hepatoma. Cases of seropositive in both HBsAg and anti-HBs group showed orcein-positive hepatocyte in 1 (33%) of 3 cases of cirrhosis with hepatoma. No orcein-positive hepatocyte was detected in cases of hepatoma without cirrhosis and in cases of non-cirrhotic non-neoplastic diseases in any serological groups.
 ...
PMID:Orcein staining of hepatitis B surface antigen in paraffin sections of liver on autopsy cases. 7 35

Hepatitis-B surface antigen (HBsAg)-positive blood which contained e antigen, when accidentally inoculated into medical personnel, resulted in hepatitis B or an anti-HBs response in 60% compared to 31% when e antigen was not detected in the inoculum. e antigen was detected in 74% of inocula sustained on chronic renal dialysis and transplantation units compared to 20% on other services and the resultant incidence of hepatitis B varied accordingly--i.e., 22% and 6% respectively. Tests for e antigen can identify the relative infectivity of groups of HBsAg carriers; technical improvements should result in valuable applications to individual cases.
 ...
PMID:Relation of e antigen to infectivity of hBsAg-positive inoculations among medical personnel. 7 62

A survey of w variants of the hepatitis B surface antigen (HBsAg) among native and immigrant Israelis revealed that the subtype ayw2 predominated among asymtpomatic HBsAg carriers (69%), and patients with acute (83%) and chronic active hepatitis B (81%). The subtypes ayw3, ayw4 and adw2, uncommon in native populations, were detected in carriage by immigrants and transients. Nevertheless, the high prevalence of ayw2 among native Israeli carriers (87%), and in particular natives with acute 93%) and chronic active hepatitis B (86%), indicates that the introduction of nonindigenous viral strains has not overtly altered the anticipated geographic distribution of hepatitis B viruses.
 ...
PMID:wVariants of the hepatitis B surface antigen in Israeli populations. 7 7

Formalin-fixed paraffin-embedded autopsy tissue of liver and tumor from 50 male black mineworkers with hepatocellular carcinoma were examined by orcein stain for the presence of cytoplasmic hepatitis B surface antigen. The results were correlated with the serum hepatitis B antigen (HBAg). In 72% serum HBAg was positive. Orcein staining of nontumor liver cell cytoplasm was present in 18 (36%). Sixteen (89%) of these orcein-positive cases were serum HBAg positive. The two false negative serum HBAg results were obtained by immunodiffusion, immunoelectrophoresis and complement fixation. Serum HBAg, measured by radio-immunoassay and hemagglutination, was positive in 14 orcein-negative cases. Six other negative orcein results appeared to be due to sampling error. Orcein staining was noted in tumor cells of three serum HBAg positive patients. Provided the limitations of the technique are realized, orcein staining of liver tissue from hepatocellular carcinoma patients may prove useful for retrospective screening surveys to assess the prevalence of HBAg positivity in these patients.
 ...
PMID:Hepatitis B antigen in black patients with hepatocellular carcinoma: correlation between orcein stained liver sections and serology. 7 53

In 31 patients with an initial diagnosis of cirrhosis or chronic hepatitis hepatocellular carcinoma (HCC) was detected after a clinical follow-up of 8 months to 14 years with an average of 59 months. They had had no scintigraphic and biochemical abnormalities suggestive of HCC at the beginning. The follow-up period before the detection of carcinoma was shorter in patients positive for hepatitis B surface antigen compared with those negative for hepatitis B surface antigen. Analyses of clinical data during the follow-up and liver scans made shortly before tumor detection suggested that in most of these patients HCC became discernible relatively early in the course of cirrhosis or long before cirrhosis reached an advanced stage. A sharp rise in serum alpha-fetoprotein level proved highly diagnostic in 11, it remained low throughout in 7, and tumor was already unresectable in the majority. Although continuous and regular check for alpha-fetoprotein is imperative in patients with chronic liver disease, particularly in those with hepatitis B surface antigenemia, additional diagnostic tools are necessary for the detection of small HCC in its resectable stage.
 ...
PMID:Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients. 7 17

No significant differences could be observed when the haptoglobine and group-specific component phenotypes of 51 unrelated, healthy carriers of antibodies to Hepatitis B surface antigen were compared with normal controls. These findings are contradictory to the suggestion of Prokop [2].
 ...
PMID:[Haptoglobin- and group-specific component-phenotypes in healthy carriers of antibodies to hepatitis B surface antigen (author's transl)]. 7 90


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>